U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
A lover of “all things Armenian,” Hovnanian dedicated himself to supporting and preserving Armenian culture and heritage.
According to Gayane Soghomonyan, six schools in Yerevan will start providing inclusive education this academic year.
The company must also ensure the people’s right to access Tsitsernakaberd, the Armenian Genocide Memorial freely.
Wearing T-shirts with the inscription "Our wounds are always open," the participants started from the Republic Square.
Partner news